The Weight-Loss Drug Revolution, Part 1: Why ...

With new breakthroughs in math and biology alongside reports of AI agents escaping and hacking systems, suffice it to say AI has had an interesting few weeks. How worried should we be about it all? Derek talks with researchers Arvind Narayanan and Sayash Kapoor, authors of the “A ...  Show more

Education outcomes have been getting worse across much of the world, with reading and math scores falling to historic lows. The U.S. has seen some of the steepest declines in decades. But, why does Mississippi look so different? Mississippi education reformer Rachel Canter has be ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  Show more